Elucidation of molecular pathogenesis of atopic dermatitis

Elucidation of molecular pathogenesis of atopic dermatitis - Elucidation of molecular pathogenesis of atopic dermatitis

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000048141

Enrollment

Registered

2022-06-24

Start date

2022-06-24

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atopic dermatitis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: [AD patient] 1) Individuals who have been diagnosed with AD according to Hanifin & Rajika's atopic dermatitis diagnostic criteria 2) Individuals who can visit to clinic (Japanese males or females) 3) Individuals providing written informed consent 4) Individuals not younger than 18 years old at the time of informed consent [Healthy subject] 1) Individuals who do not have skin diseases 2) Individuals who can visit to clinic (Japanese males or females) 3) Individuals providing written informed consent 4) Individuals not younger than 18 years old at the time of informed consent

Exclusion criteria

Exclusion criteria: 1) Individuals who are judged to be prone to complications by skin biopsy 2) Individuals who are or are possibly pregnant, or are lactating 3) Individuals who have severe skin diseases other than AD 4) Individuals who have difficulty with anesthetics or who have experienced illness due to anesthetics 5) Individuals without capacity to consent 6) Individuals judged inappropriate for the study by a doctor

Design outcomes

Primary

Measure	Time frame
Immunohistological and biochemical analysis	—

Countries

Japan

Contacts

Public ContactYoshiki Kubota

NANOEGG Research Laboratories, Inc. Pharmaceutical Products Research and Development Section

yoshiki-kubota@nanoegg.co.jp044-400-1155

Outcome results